Director Stewart Brady purchased 30,000 shares of EOLS at $6.82, raising stake 51.2% amid 61.8% decline from 52-week high.
Stewart Brady, a Director, acquired 30,000 shares at $6.82 on August 15, 2025, substantially increasing his position from 58,629 shares to 88,629 shares (a 51.2% increase in holdings). The purchase occurred as the stock trades at $6.69, down 61.8% from its 52-week high of $17.49 and down 27.3% over the prior 30 days. Evolus is currently unprofitable with a net loss of $-17.1M against quarterly revenue of $69.4M, though the company posted annual revenue growth of 31.8% year-over-year. The transaction signals director accumulation during a steep drawdown, which may merit scrutiny given the stock's significant distance from recent highs and the company's ongoing losses, though strong top-line growth provides some operational counterweight.